A study to determine the efficacy of COVID-19 mRNA vaccines and compared the SARS-CoV-2 genomes Alpha and Iota variants after full vaccination with BNT162b2 (Pfizer/BioNTech), mRNA-1273 (Moderna), or JNJ-78436735 (Janssen) in metropolitan New York
Latest Information Update: 15 Oct 2021
Price :
$35 *
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary) ; Ad26.COV2 S
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 15 Oct 2021 New trial record
- 15 Sep 2021 Results published in the Journal of Clinical Investigation